Suppr超能文献

对极早早产儿使用对乙酰氨基酚预防动脉导管未闭:越南一项单机构观察性研究

Prophylaxis of Patent Ductus Arteriosus with Paracetamol in Extremely Low Gestational Age Newborns (ELGANs): A Single-Institution Observational Study in Vietnam.

作者信息

Nguyen Tinh Thu, Nguyen Dung Thi Ngoc, Pham Tam Thi Thanh, Oei Ju-Lee

机构信息

Department of Pediatrics, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam.

Neonatal Intensive Care Unit, Children's Hospital 2, Ho Chi Minh City 700000, Vietnam.

出版信息

Children (Basel). 2023 Dec 17;10(12):1934. doi: 10.3390/children10121934.

Abstract

INTRODUCTION

Prophylactic paracetamol for extremely low gestation age neonates (ELGAN, <27 weeks' gestation) with symptomatic patent ductus arteriosus (sPDA) in high-income countries (HIC) reduces medical and surgical interventions. Its effectiveness in low-to-middle-income countries (LMIC) remains uncertain. This study assesses prophylactic paracetamol's impact on sPDA interventions in ELGANs in an LMIC.

METHODS

This is a retrospective cohort study that compared a historical cohort of ELGANs that were treated with oral ibuprofen or intravenous paracetamol after diagnosis of sPDA ( = 104) with infants ( = 76) treated with prophylactic paracetamol (20 mg/kg loading, 7.5 mg/kg qid for 4 days), in a tertiary neonatal intensive care unit (NICU) in Vietnam. Oral ibuprofen or intravenous therapeutic paracetamol were administered if prophylactic paracetamol failed to close sPDA. Surgical ligation was conducted if targeted medical intervention failed, or the infant deteriorated from conditions attributable to sPDA.

RESULTS

In the historical cohort, 57 (55%) infants died within 7 days of life compared to 18 (24%) from the prophylactic cohort ( < 0.01). Of the survivors, 21 (45%) of the historical and 23 (39.7%) of the prophylactic cohort required surgical ligation ( = 0.6). Duration of hospitalization for survivors was lower in the prophylactic cohort (mean 74 vs. 97 days, = 0.01). In the prophylactic cohort, 24 (41%) infants did not need further treatment while 34 (59%) required further treatment including ibuprofen and/or paracetamol 28 (48%) and surgical ligation 22 (38%).

CONCLUSIONS

Prophylactic paracetamol for ELGAN in LMIC does not reduce the need for surgical ligation, sPDA rates, and other PDA-related morbidities in infants who survive beyond 7 days of age. It may reduce the risk of death and the duration of hospitalization but further study into the reasons behind this need to be determined with larger studies.

摘要

引言

在高收入国家(HIC),对孕周极短的新生儿(ELGAN,孕周<27周)且患有有症状的动脉导管未闭(sPDA)者使用对乙酰氨基酚进行预防,可减少医疗和手术干预。其在中低收入国家(LMIC)的有效性仍不确定。本研究评估了预防性使用对乙酰氨基酚对中低收入国家孕周极短新生儿sPDA干预措施的影响。

方法

这是一项回顾性队列研究,在越南一家三级新生儿重症监护病房(NICU)中,将确诊sPDA后接受口服布洛芬或静脉注射对乙酰氨基酚治疗的孕周极短新生儿历史队列(n = 104)与接受预防性对乙酰氨基酚治疗(负荷剂量20 mg/kg,每日4次,每次7.5 mg/kg,共4天)的婴儿(n = 76)进行比较。如果预防性使用对乙酰氨基酚未能闭合sPDA,则给予口服布洛芬或静脉注射治疗性对乙酰氨基酚。如果靶向药物干预失败,或婴儿因sPDA导致病情恶化,则进行手术结扎。

结果

在历史队列中,57名(55%)婴儿在出生后7天内死亡,而预防性队列中有18名(24%)(P<0.01)。在幸存者中,历史队列中有21名(45%),预防性队列中有23名(39.7%)需要进行手术结扎(P = 0.6)。预防性队列中幸存者的住院时间较短(平均74天对97天,P = 0.01)。在预防性队列中,24名(41%)婴儿无需进一步治疗,而34名(59%)需要进一步治疗,包括布洛芬和/或对乙酰氨基酚28名(48%)以及手术结扎22名(38%)。

结论

在中低收入国家,对孕周极短新生儿预防性使用对乙酰氨基酚并不能减少7日龄以上存活婴儿的手术结扎需求、sPDA发生率及其他与PDA相关的发病率。它可能会降低死亡风险和住院时间,但需要通过更大规模的研究进一步确定其背后的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82cc/10741618/5b33afdc60f6/children-10-01934-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验